1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol,
1-deoxy-galactonojirimycin,
1-deoxygalacto-nojirimycin,
1-deoxygalactonojirimycin,
AT1001 deoxyjirimycin,
GR181413A,
lucerastat,
migalastat,
migalastat HCl,
migalastat hydrochloride,
N-butyldeoxygalacto-nojirimycin,
N-butyldeoxygalactonojirimycin,
NB-DGJ,
Lucerastat,
141206-42-0,
UNII-GVS3YDM418,
N-Butyldeoxygalactonojirimycin,
N-(n-Butyl)deoxygalactonojirimycin,
GVS3YDM418,
CHEMBL1086997,
(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol,
Lucerastat [INN],
N-Butyl-1-deoxygalactonojirimycin,
N-Butyl-DGJ,
Lucerastat [USAN],
N-Bu-DGJ,
NB-DGJ,
AC1L9UXN,
N- Butyldeoxygalactonojirimycin,
SCHEMBL6821044,
N-Butyl-deoxy-galactonojirimycin,
CDP-923,
DTXSID60161601,
N-N-Butyl Deoxygalactonojirimycin,
OGT-923,
WHO 9539,
ZX-AT009021,
BDBM50312528,
MFCD00269939,
ZINC13719785,
N-Butyl-D-galacto-1-deoxynojirimycin,
ACT-434964,
SB18742,
NCGC00181326-01,
LS-116260,
1-Butyl-2-hydroxymethyl-piperidine-3,4,5-triol,
W-201205,
(2R,3S,4R,5S)-1-(But-1-yl)-2-(hydroxymethyl)piperidine-3,4,5-triol,
Miglustat,
Lacto-N-tetraose,
N-butylgalactonojirimycin,
CID501391,